Genetic alterations in metabolic genes associated with metastatic progression analyzed, revealed that genes involved in cellular fatty acid uptake (CAV1, CD36) and de novo lipogenesis (PPARA, PPARD, MLXIPL) were specifically amplified at higher frequencies in metastatic tumors (Nath and Chan, 2016). This evidence concerns the gene CAV1 and metastatic neoplasm.